Enhanced TROSY Effect in [2-19 F, 2-13 C] Adenosine and ATP Analogs Facilitates NMR Spectroscopy of Very Large Biological RNAs in Solution
- PMID: 38185473
- PMCID: PMC10922520
- DOI: 10.1002/anie.202316273
Enhanced TROSY Effect in [2-19 F, 2-13 C] Adenosine and ATP Analogs Facilitates NMR Spectroscopy of Very Large Biological RNAs in Solution
Abstract
Large RNAs are central to cellular functions, but characterizing such RNAs remains challenging by solution NMR. We present two labeling technologies based on [2-19 F, 2-13 C]-adenosine, which allow the incorporation of aromatic 19 F-13 C spin pairs. The labels when coupled with the transverse relaxation optimized spectroscopy (TROSY) enable us to probe RNAs comprising up to 124 nucleotides. With our new [2-19 F, 2-13 C]-adenosine-phosphoramidite, all resonances of the human hepatitis B virus epsilon RNA could be readily assigned. With [2-19 F, 2-13 C]-adenosine triphosphate, the 124 nt pre-miR-17-NPSL1-RNA was produced via in vitro transcription and the TROSY spectrum of this 40 kDa [2-19 F, 2-13 C]-A-labeled RNA featured sharper resonances than the [2-1 H, 2-13 C]-A sample. The mutual cancelation of the chemical-shift-anisotropy and the dipole-dipole-components of TROSY-resonances leads to narrow linewidths over a wide range of molecular weights. With the synthesis of a non-hydrolysable [2-19 F, 2-13 C]-adenosine-triphosphate, we facilitate the probing of co-factor binding in kinase complexes and NMR-based inhibitor binding studies in such systems. Our labels allow a straightforward assignment for larger RNAs via a divide-and-conquer/mutational approach. The new [2-19 F, 2-13 C]-adenosine precursors are a valuable addition to the RNA NMR toolbox and will allow the study of large RNAs/RNA protein complexes in vitro and in cells.
Keywords: 19F NMR; RNA Dynamics; RNA Labelling; TROSY NMR.
© 2024 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Conflict of interest statement
CONFLICT OF INTEREST
CK is an advisor to and holds an ownership interest in Innotope, a company providing RNA stable isotope labeling products. The remaining authors declare no competing interests.
References
-
- Bao H-L, Xu Y, Nature Protocols 2018, 13, 652; - PubMed
- Fauster K, Kreutz C, Micura R, Angewandte Chemie International Edition 2012, 51, 13080; - PMC - PubMed
- Lu M, Wang M, Sergeyev IV, Quinn CM, Struppe J, Rosay M, Maas W, Gronenborn AM, Polenova T, Journal of the American Chemical Society 2019, 141, 5681; - PMC - PubMed
- Orton HW, Qianzhu H, Abdelkader EH, Habel EI, Tan YJ, Frkic RL, Jackson CJ, Huber T, Otting G, Journal of the American Chemical Society 2021, 143, 19587; - PubMed
- Zhao C, Devany M, Greenbaum NL, Biochemical and Biophysical Research Communications 2014, 453, 692; - PubMed
- Ishizuka T, Bao H-L, Xu Y in G-Quadruplex Nucleic Acids: Methods and Protocols (Eds.: Yang D, Lin C), Springer New York, New York, NY, 2019, pp. 407–433;
- Eichler C, Himmelstoß M, Plangger R, Weber LI, Hartl M, Kreutz C, Micura R, Chemistry – A European Journal 2023, 29, e202302220. - PMC - PubMed
-
- Klingler D, Huber M, Tollinger M, Kreutz C, Journal of Magnetic Resonance Open 2022, 12–13, 100077.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials